SS Innovations International Inc(US:SSII) Globenewswire·2025-05-05 12:30Core Viewpoint - SS Innovations International, Inc. is focused on making robotic surgery affordable and accessible globally, and it has reiterated its guidance for the first quarter of 2025, indicating a positive growth trajectory following its uplisting to Nasdaq [1][2]. Company Updates - The company anticipates reporting its first quarter 2025 financial results around May 15, 2025 [2]. - As of March 31, 2025, a total of 78 SSi Mantra surgical robotic systems have been installed, with 14 systems installed during the first quarter of 2025 [6]. - Revenue for the first quarter of 2025 is expected to be approximately $6.4 million, with a gross margin of around 45% based on preliminary unaudited results [6]. - By April 30, 2025, 80 SSi Mantra robotic surgical systems were installed in 75 hospitals, and over 3,800 surgeries have utilized the SSi Mantra, including more than 200 robotic cardiac surgeries [6]. - In April 2025, the company received 9 orders for the SSi Mantra robotic surgical system, representing a 200% increase from 3 orders in April 2024 [6]. Product Information - The SSi Mantra Surgical Robotic System features a modular design with 3 to 5 robotic arms, an ergonomic surgeon command center, a large 3D 4K monitor, and a virtual real-time image display [4]. - The system supports various surgical specialties, including cardiac surgery, and has been clinically validated in over 100 different types of surgical procedures in India [4].